APA (7th ed.) Citation

Lübke, J., Naumann, N., Kluger, S., Schwaab, J., Metzgeroth, G., Hofmann, W., . . . Jawhar, M. (2019). Inhibitory effects of midostaurin and avapritinib on myeloid progenitors derived from patients with KIT D816V positive advanced systemic mastocytosis. Leukemia, 33(5), . https://doi.org/10.1038/s41375-019-0450-8

Chicago Style (17th ed.) Citation

Lübke, Johannes, Nicole Naumann, Sebastian Kluger, Juliana Schwaab, Georgia Metzgeroth, Wolf-Karsten Hofmann, Alice Fabarius, Andreas Reiter, and Mohamad Jawhar. "Inhibitory Effects of Midostaurin and Avapritinib on Myeloid Progenitors Derived from Patients with KIT D816V Positive Advanced Systemic Mastocytosis." Leukemia 33, no. 5 (2019). https://doi.org/10.1038/s41375-019-0450-8.

MLA (9th ed.) Citation

Lübke, Johannes, et al. "Inhibitory Effects of Midostaurin and Avapritinib on Myeloid Progenitors Derived from Patients with KIT D816V Positive Advanced Systemic Mastocytosis." Leukemia, vol. 33, no. 5, 2019, https://doi.org/10.1038/s41375-019-0450-8.